376 related articles for article (PubMed ID: 35682953)
1. Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer.
Ruscitto F; Roda N; Priami C; Migliaccio E; Pelicci PG
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682953
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
Ullah I; Karthik GM; Alkodsi A; Kjällquist U; Stålhammar G; Lövrot J; Martinez NF; Lagergren J; Hautaniemi S; Hartman J; Bergh J
J Clin Invest; 2018 Apr; 128(4):1355-1370. PubMed ID: 29480816
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
Menyailo ME; Tretyakova MS; Denisov EV
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
[TBL] [Abstract][Full Text] [Related]
4. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
5. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.
Kulkarni S; Augoff K; Rivera L; McCue B; Khoury T; Groman A; Zhang L; Tian L; Sossey-Alaoui K
PLoS One; 2012; 7(8):e42895. PubMed ID: 22952619
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
7. [Role of biological heterogeneity in recurrent and metastatic breast cancer].
Kolyadina IV; Andreeva YY; Frank GA; Poddubnaya IV
Arkh Patol; 2018; 80(6):62-67. PubMed ID: 30585595
[TBL] [Abstract][Full Text] [Related]
8. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.
Venet D; Fimereli D; Rothé F; Boeckx B; Maetens M; Majjaj S; Rouas G; Capra M; Bonizzi G; Contaldo F; Galant C; Piccart M; Pruneri G; Larsimont D; Lambrechts D; Desmedt C; Sotiriou C
EBioMedicine; 2020 Jun; 56():102793. PubMed ID: 32512508
[TBL] [Abstract][Full Text] [Related]
9. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
[TBL] [Abstract][Full Text] [Related]
10. Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy.
Montagna E; Vingiani A; Maisonneuve P; Cancello G; Contaldo F; Pruneri G; Colleoni M
Breast; 2017 Aug; 34():83-88. PubMed ID: 28544923
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
12. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.
Wendt MK; Williams WK; Pascuzzi PE; Balanis NG; Schiemann BJ; Carlin CR; Schiemann WP
Neoplasia; 2015 Jan; 17(1):124-33. PubMed ID: 25622905
[TBL] [Abstract][Full Text] [Related]
13. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
14. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
Punzi S; Balestrieri C; D'Alesio C; Bossi D; Dellino GI; Gatti E; Pruneri G; Criscitiello C; Lovati G; Meliksetyan M; Carugo A; Curigliano G; Natoli G; Pelicci PG; Lanfrancone L
Breast Cancer Res; 2019 Nov; 21(1):123. PubMed ID: 31752957
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells.
Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA
Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882
[TBL] [Abstract][Full Text] [Related]
16. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
17. Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling.
Vella V; De Francesco EM; Lappano R; Muoio MG; Manzella L; Maggiolini M; Belfiore A
Front Cell Dev Biol; 2020; 8():608412. PubMed ID: 33364239
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Constrains Rule Metastasis Progression.
Roda N; Gambino V; Giorgio M
Cells; 2020 Sep; 9(9):. PubMed ID: 32932943
[TBL] [Abstract][Full Text] [Related]
19. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
[TBL] [Abstract][Full Text] [Related]
20. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]